Artikel von David Engelhardt

David Engelhardt has been employed in equity research at TraderFox GmbH since April 2022. David completed his Bachelor's degree in Economics at Friedrich-Alexander-University in Erlangen-Nuremberg in 2018 and subsequently obtained a Master's degree in Business Administration at the University of Bamberg. Since 2019, he has been independently engaged with the topics of stock markets, equities, and capital markets. For the equity magazine, he is mainly responsible for the Hot News section and regularly publishes his own articles there. Since March 2023, he has been reporting as the editor-in-chief for the Traderfox equity magazine Small Caps Investor about small companies with enormous growth potential.

Latest from David Engelhardt

BorgWarner: The Pragmatic bet on the Future of Mobility

In the currently volatile landscape of automotive suppliers , BorgWarner (NYSE: BWA) has developed into...

Dana Inc.: Electrification as a Turbo: the Company Reinvents Itself

Dana is currently undergoing a significant transformation from a traditional mechanical supplier to...

Hershey: The Sweetest Comeback of the Year

At the stock exchange, courage is often rewarded, and few examples have illustrated this as clearly as...

Granite Construction: The Architect of American Infrastructure

Granite Construction is massively benefiting from long-term US funding programs like the IIJA, which...

Siemens Energy Starts Fiscal Year 2026 with Record Values

The energy technology company Siemens Energy released figures on February 11, 2026, that profoundly underscore...

Precision meets Profit: How Graco is conquering the industrial markets of tomorrow through Automation and High-Tech

In a market environment that increasingly relies on fundamental stability by 2026, Graco's stock (NYSE:...

Regal Rexnord: The Unknown Giant Shaping the World

Through the strategic acquisition of Altra Industrial Motion, the company has successfully transformed...

Kering Aims for a Return to Growth While Efforts for a Gucci Comeback Continue

The company expects a return to growth this year   Strategic realignment and turnaround plans  ...

The Toll Booth of Modernity: Why Visa Belongs in Every Long-Term Portfolio

In an age where investors often chase fleeting technology trends, Visa's stock (i) represents a rare...

Revolution Medicine: Targeting Cancer Mutation and the Billion-Dollar Potential of RAS Inhibitors

Revolution Medicine is a global leader in the development of RAS(ON) inhibitors, which, unlike traditional...

Innovent Biologics: Billion-Dollar Deal with Eli Lilly Finalized

The new partnership involves the joint development of new medications by both companies. This marks already...

The Andersons: Commodity Logistics Meets Renewable Energy

The company acts as a robust link in the agricultural value chain by skillfully combining traditional...

Amgen: The Defensive Anchor in the Biotech Sector

In the often volatile world of biotechnology, Amgen (i) has established itself as a rare constant, offering...

Reddit shines with record numbers: Advertising boom massively boosts quarterly profit

The social media platform Reddit has had an impressive fourth quarter, significantly surpassing Wall...

Powell Industries: The Nerve Center of American Re-Industrialization

Powell Industries acts not just as a mere components manufacturer but as an indispensable engineering...

Why Duolingo Deserves a Second Chance Now

Duolingo's stock has been battered over the past few months and is now trading nearly 80% below its peak....

Arm Holdings: AI Boom Meets Seasonal {[Headwinds]}

The British heavyweight in chip design, Arm Holdings, is heading into a transition quarter. Despite the...

Thermon Group Holdings: A Hidden Champion of the Energy Transition to Keep an Eye On!

In the current market phase, where investors often fluctuate between volatile tech stocks and cyclical...

Scholar Rock Holdings: Between Approval Hopes and Billion-Dollar Niche

Scholar Rock is the first company to achieve clinical Phase-3 success with a highly selective myostatin...

Infineon Increases Investments Amid Unbroken Demand for AI Chips

The company plans to spend around €2.7 billion in the fiscal year 2026 to expand production capacities...